Provisio Medical, founded with a mission to revolutionize endovascular procedures, focuses on developing innovative medical devices using Sonic Lumen Tomography (SLT™). This novel intravascular ultrasound technology offers precise, real-time flow lumen measurements, enhancing procedural workflows and improving clinical outcomes. Provisio's SLT platform integrates seamlessly with existing endovascular devices, eliminating the need for ionizing radiation and kidney-toxic contrast media used in traditional angiography. The company targets healthcare providers and institutions specializing in vascular treatments.

Provisio Medical has garnered attention from notable investors and industry experts due to its groundbreaking technology. The company's key achievements include the successful development and initial deployment of the SLT platform, which has shown significant potential in improving the accuracy and safety of endovascular procedures. By addressing critical limitations of current imaging techniques, Provisio Medical is poised to make a substantial impact on the field of vascular medicine, enhancing patient care and procedural efficiency.